STOCK TITAN

Marsh McLennan’s Oliver Wyman to Acquire Healthcare Analytics Business Validate Health

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Positive)

NEW YORK--(BUSINESS WIRE)-- Oliver Wyman, a global leader in management consulting and a business of Marsh McLennan (NYSE: MMC), today announced an agreement to acquire Validate Health, a healthcare analytics business that enables healthcare providers and Accountable Care Organizations (ACOs) to better manage costs, risk, and performance. The terms of the transaction, expected to close in summer 2025, were not disclosed.

Validate Health will join Oliver Wyman Actuarial, a specialized business within Oliver Wyman that provides actuarial services to insurers, investors, healthcare providers, corporates and other clients. The acquisition strengthens the business through powerful analytic and technology solutions that help clients grow market size, increase margins, optimize programs, manage risk, and secure investments and funding, while also enhancing patient outcomes.

“Healthcare is a complex and critical industry featuring a unique set of challenges, and it is undergoing a seismic shift,” said David Weinsier, Partner, Global Life and Health Leader for Oliver Wyman Actuarial. “This acquisition allows us to not only meet that moment but lead it. By combining our deep actuarial and policy expertise with Validate Health’s data-driven solutions, we are at the forefront of building an analytics platform that helps clients improve healthcare delivery and drive efficiency.”

Andrew Webster, Validate Health Co-Founder, added, “This is a milestone moment for us. From the start, our mission has been to make healthcare better through data. Joining forces with Oliver Wyman gives us the reach, actuarial and insurance expertise, and complementary skillsets to supercharge that mission. Our clients – and their patients – stand to gain the most.”

For more information about Oliver Wyman Actuarial services, visit our Actuarial Consulting website.

About Oliver Wyman

Oliver Wyman, a business of Marsh McLennan (NYSE: MMC), is a management consulting firm combining deep industry knowledge with specialized expertise to help clients optimize their business, improve operations and accelerate performance. Marsh McLennan is a global leader in risk, strategy and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective. For more information, visit marshmclennan.com, follow us on LinkedIn and X.

About Validate Health

Validate Health provides ongoing actuarial and financial optimization services customized for Accountable Care Organizations (ACOs). It reconstructs the Centers for Medicare and Medicaid Services (CMS) methodology using computer models for MSSP, REACH, Medicare Advantage, and other accountable care programs. Depending on the decision needed, Validate Health simulates the impact of multiple scenarios at different organizational levels, time horizons, and decision frequencies.

Danielle Arceneaux

1 (212) 345 0198

danielle.arceneaux@mmc.com

Source: Oliver Wyman

Marsh & Mclennan

NYSE:MMC

MMC Rankings

MMC Latest News

MMC Stock Data

106.44B
492.33M
0.1%
92.16%
1.1%
Insurance Brokers
Insurance Agents, Brokers & Service
Link
United States
NEW YORK